LCTX vs UBER · rev $9.5M vs P/E 18, rev $52.02B
Lineage Cell Therapeutics Inc (LCTX) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
LCTX currently screens at market cap $213.6M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the LCTX and UBER stock pages for the full models.
Not investment advice.